Folsom Metal Products Recalls Distraction Pins Over Labeling Issues
Folsom Metal Products recalled 490 units of its 16 mm distraction pin on August 21, 2025. The recall affects devices with unvalidated shelf life labeling. Patients and healthcare providers must stop using the device immediately.
Quick Facts at a Glance
Recall Date
August 21, 2025
Hazard Level
HIGH
Brand
Folsom Metal Products
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL
Hazard Information
Labeling includes shelf life that has not been validated.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Folsom Metal Products, Inc. or your healthcare provider for instructions. Notification method: Letter
Product Details
The recalled product is the 16 mm distraction pin, REF: 301.916S1, sold in 10 single packs. It has been distributed nationwide in states including California, Florida, and Texas.
The Hazard
The labeling of these distraction pins includes a shelf life that has not been validated. This could lead to the use of ineffective or unsafe medical devices.
Reported Incidents
There are no reported incidents or injuries related to this recall. The recall is precautionary due to labeling issues.
What to Do
Stop using the distraction pins immediately. Contact Folsom Metal Products, Inc. or your healthcare provider for further instructions.
Contact Information
For more information, visit the FDA website or contact Folsom Metal Products, Inc. directly at their customer service number.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.